Janux Therapeutics News

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dobek Maria

Aug 10 07:08

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%), etc.

Aug 10 04:13

Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director DOBMEIER ERIC

Jul 25 08:05

Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Hernday Natasha

Jul 25 08:05

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DOBMEIER ERIC

Jul 23 08:07

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hernday Natasha

Jul 23 08:07

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DOBMEIER ERIC

Jul 23 08:02

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hernday Natasha

Jul 23 08:02

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Jun 29 04:39

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simson Jake

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrett Ronald W

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kung Winston

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McNulty Alana B.

Jun 29 04:34

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay

Jun 29 04:34

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(14.1%),Tighe Reardon(8.5%), etc.

Jun 6 07:32

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay

Jun 6 07:27

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Tighe

Jun 6 07:27

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.

Jun 6 07:22